Cargando…

Whole-transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1-MET fusion-negative secondary glioblastoma multiforme

Gliomas are the most common type of primary brain tumor in adults with a high mortality rate. Low-grade gliomas progress to glioblastoma multiforme (GBM) in the majority of cases, forming secondary GBM (sGBM), followed by rapid fatal clinical outcomes. Protein tyrosine phosphatase receptor type Z1 (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Bao-Shi, Wang, Kuan-Yu, Yu, Shu-Qing, Zhang, Chuan-Bao, Li, Guan-Zhang, Wang, Zhi-Liang, Bao, Zhao-Shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479526/ https://www.ncbi.nlm.nih.gov/pubmed/32952656 http://dx.doi.org/10.3892/ol.2020.12049

Ejemplares similares

RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas
por: Bao, Zhao-Shi, et al.
Publicado: (2014)

Recurrent PTPRZ1‐MET fusion and a high occurrence rate of MET exon 14 skipping in brain metastases
por: Chai, Rui‐Chao, et al.
Publicado: (2021)

Tumour exosomes from cells harbouring PTPRZ1–MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma
por: Zeng, A-L, et al.
Publicado: (2017)

Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth
por: Shi, Yu, et al.
Publicado: (2017)

High‐sensitive clinical diagnostic method for PTPRZ1‐MET and the characteristic protein structure contributing to ligand‐independent MET activation
por: Huang, Ruoyu, et al.
Publicado: (2021)

PTPRZ1-METFUsion GENe (ZM-FUGEN) trial: study protocol for a multicentric, randomized, open-label phase II/III trial
por: Bao, Zhaoshi, et al.
Publicado: (2023)

Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells
por: Fujikawa, Akihiro, et al.
Publicado: (2017)

Longevity-Related Gene Transcriptomic Signature in Glioblastoma Multiforme
por: Fawzy, Manal S., et al.
Publicado: (2018)

NTRK1 Fusion in Glioblastoma Multiforme
por: Kim, Jinkuk, et al.
Publicado: (2014)

Small-molecule inhibition of PTPRZ reduces tumor growth in a rat model of glioblastoma
por: Fujikawa, Akihiro, et al.
Publicado: (2016)

Network Signatures of Survival in Glioblastoma Multiforme
por: Patel, Vishal N., et al.
Publicado: (2013)

Correction: NTRK1 Fusion in Glioblastoma Multiforme
Publicado: (2014)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients
por: Gao, Wei-Zhen, et al.
Publicado: (2018)

MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas
por: Wang, Qiang-Wei, et al.
Publicado: (2021)

Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme
por: Bernal Rubio, Yeni L., et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

A risk signature with four autophagy‐related genes for predicting survival of glioblastoma multiforme
por: Wang, Yulin, et al.
Publicado: (2020)

Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme
por: Yu, Ziye, et al.
Publicado: (2022)

Secondary gliosarcoma after the treatment of primary glioblastoma multiforme
por: Andaloussi-Saghir, Khalid, et al.
Publicado: (2011)

Modulation of Tumor Immune Microenvironment and Prognostic Value of Ferroptosis-Related Genes, and Candidate Target Drugs in Glioblastoma Multiforme
por: Zhang, Xudong, et al.
Publicado: (2022)

A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme
por: Zhao, Jingwei, et al.
Publicado: (2019)

Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis
por: Chen, Xiaojie, et al.
Publicado: (2020)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling
por: Guo, Xiao-Yu, et al.
Publicado: (2021)

Chromosomal Instability and Phosphoinositide Pathway Gene Signatures in Glioblastoma Multiforme
por: Waugh, Mark G.
Publicado: (2014)

ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme
por: Zhao, Zheng, et al.
Publicado: (2019)

Acquired MET Expression Confers Resistance to EGFR Inhibition In a Mouse Model of Glioblastoma Multiforme
por: Jun, Hyun Jung, et al.
Publicado: (2011)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
por: Yang, Ji’an, et al.
Publicado: (2020)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Extracranial metastases in secondary glioblastoma multiforme: a case report
por: Rossi, Jessica, et al.
Publicado: (2020)

Aptamer-Modified Erythrocyte Membrane-Coated pH-Sensitive Nanoparticles for c-Met-Targeted Therapy of Glioblastoma Multiforme
por: Liu, Xianping, et al.
Publicado: (2022)

A Novel Six-mRNA Signature Predicts Survival of Patients With Glioblastoma Multiforme
por: Liu, Zhentao, et al.
Publicado: (2021)

Genomic Analysis of Glioblastoma Multiforme Reveals a Key Transcription Factor Signature Relevant to Prognosis and the Immune Processes
por: Li, Zhen-Hang, et al.
Publicado: (2021)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Identification of a cullin5-RING E3 ligase transcriptome signature in glioblastoma multiforme
por: Zheng, Shuhua, et al.
Publicado: (2020)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Overexpression of c-Met is Associated with Poor Prognosis in Glioblastoma Multiforme: A Systematic Review and Meta-Analyses
por: Anton, Jellyca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ukjvuuq7fs0jnffc3minnjamem